Autoantigens act as tissue-specific chemoattractants
Joost J. Oppenheim(Frederick National Laboratory for Cancer Research), O. M. Zack Howard(Center for Cancer Research), Susan K. Pierce(National Institute of Allergy and Infectious Diseases), Roland Martinꝉ(University of Zurich), Paul H. Plötz(National Institutes of Health), Hui Dong(Shandong University), Omanand Koul(University of Massachusetts Chan Medical School), Michelle Dykstra(National Institute of Allergy and Infectious Diseases), Rachel R Caspi(National Institutes of Health), Casey A. Carlos(UPMC Hillman Cancer Center), Olivera J. Finn(University of Pittsburgh)
Cited by 49
Related Papers
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
|Clinical Cancer Research|2009|1.4k
Therapy of Lupus Nephritis
|New England Journal of Medicine|1986|1.2k
A New Approach to the Classification of Idiopathic Inflammatory Myopathy
|Medicine|1991|974
Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line.
|The Journal of Experimental Medicine|1989|765
Cancer vaccines: between the idea and the reality
|Nature reviews. Immunology|2003|633